title: Off-label reports of new biologics: exciting new therapy or dubious research? Examples from recombinant activated factor VII.
authors.forename: Michael
authors.initials: M
authors.lastname: Shalmi
authors.forename: Peter
authors.initials: P
authors.lastname: Aurup
mesh_terms: D001688:Biological Products / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004348:Drug Labeling; D015507:Drugs, Investigational / Q000627:therapeutic use*; D026690:Ethics, Clinical; D005167:Factor VII / Q000627:therapeutic use*; D015942:Factor VIIa; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D001688:Biological Products; D015507:Drugs, Investigational; D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa